Vertex Pharma upgraded at Canaccord Genuity after Q4 results
Vertex Pharmaceuticals (NASDAQ:VRTX) received an upgrade from Canaccord Genuity after the cystic fibrosis drugmaker exceeded consensus revenue estimates but missed on earnings with its Q4 2024 ...
Raw Story on MSN28m
Russell Vought's kid got life-saving drug — that his policies are now attacking: report
The daughter of a key architect of Project 2025 benefitted from a life-changing drug — which was created with the help of the ...